Equities

Kronox Lab Sciences Ltd

KRONOX:NSI

Kronox Lab Sciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)178.53
  • Today's Change3.53 / 2.02%
  • Shares traded248.41k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments363628
Total Receivables, Net224193266
Total Inventory939275
Prepaid expenses0.580.370.58
Other current assets, total1132172
Total current assets466342442
Property, plant & equipment, net269159113
Goodwill, net------
Intangibles, net------
Long term investments0.25350.25
Note receivable - long term----0
Other long term assets0.970.759.75
Total assets740540568
LIABILITIES
Accounts payable6278115
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0012
Other current liabilities, total149.8610
Total current liabilities7788138
Total long term debt0022
Total debt0034
Deferred income tax------
Minority interest------
Other liabilities, total0.184.875.20
Total liabilities7793164
SHAREHOLDERS EQUITY
Common stock3713712.41
Additional paid-in capital------
Retained earnings (accumulated deficit)28975402
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total3.251.22(0.88)
Total equity663448404
Total liabilities & shareholders' equity740540568
Total common shares outstanding373737
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.